Idarubicin containing regimen in multiple myeloma: preliminary results of a pilot study using a modified "TANDEM" transplant program. (Q44398780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Idarubicin containing regimen in multiple myeloma: preliminary results of a pilot study using a modified "TANDEM" transplant program (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

G Martinelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Agazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Laszlo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Santoro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Mancuso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G C Pruneri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Greco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

299-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

Intensive treatment of multiple myeloma and criteria for complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000029687

10.1080/1042819021000029687

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12688348%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference